Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug composition for NSCLC (Non Small Cell Lung Cancer) prevention and preparation method thereof

A technology for non-small cell lung cancer and a composition, applied in the field of medicine, can solve problems such as unsatisfactory use and threat to the life safety of patients

Inactive Publication Date: 2015-04-29
QINGDAO MUNICIPAL HOSPITAL
View PDF3 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is a serious threat to the life safety of patients. Although there are many drugs for the treatment of non-small cell lung cancer, their use is not satisfactory due to various reasons. Traditional Chinese medicine has rich resources and unique features for the treatment of difficult and miscellaneous diseases. Therefore, How to use traditional Chinese medicine to treat non-small cell lung cancer is a technical problem that needs to be solved urgently

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] A kind of anti-non-small cell lung cancer pharmaceutical composition of the present invention, take following traditional Chinese medicine crude drug: astragalus root 10 grams, Radix Pseudostellariae 13 grams, Ophiopogon japonicus 17 grams, Schisandra chinensis 20 grams, Cordyceps sinensis 21 grams, Codonopsis 10 grams, Chuanbei 15 grams grams, 7 grams of bitter almonds, 4 grams of loquat leaves, 13 grams of Houttuynia cordata, 19 grams of angelica, 11 grams of Panax notoginseng, 22 grams of antler, 27 grams of leeches, 18 grams of Hedyotis diffusa, 9 grams of Prunella vulgaris, Scutellaria barbata 15 grams, bezoar 12 grams, centipede 11 grams.

Embodiment 2

[0049] A kind of anti-non-small cell lung cancer pharmaceutical composition of the present invention, take the following traditional Chinese medicine raw materials: Astragalus 13 grams, Radix Pseudostellariae 17 grams, Ophiopogon japonicus 30 grams, Schisandra chinensis 14 grams, Cordyceps sinensis 23 grams, Codonopsis 6 grams, Chuanbei 13 grams 6 grams of bitter almonds, 9 grams of loquat leaves, 11 grams of Houttuynia cordata, 15 grams of angelica, 8 grams of Sanqi, 19 grams of antler, 30 grams of leeches, 13 grams of Hedyotis diffusa, 5 grams of Prunella vulgaris, barbata 9 grams, bezoar 10 grams, centipede 12 grams.

Embodiment 3

[0051] A kind of anti-non-small cell lung cancer pharmaceutical composition of the present invention, take following traditional Chinese medicine crude drug: astragalus root 8 grams, Radix Pseudostellariae 20 grams, Ophiopogon japonicus 19 grams, Schisandra chinensis 27 grams, Cordyceps sinensis 17 grams, Codonopsis 5 grams, Chuanbei 19 grams 10 grams of bitter almonds, 6 grams of loquat leaves, 15 grams of Houttuynia cordata, 14 grams of angelica, 18 grams of Panax notoginseng, 27 grams of antler, 32 grams of leeches, 15 grams of Hedyotis diffusa, 4 grams of Prunella vulgaris, Scutellaria barbata 12 grams, bezoar 8 grams, centipede 7 grams.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A drug composition for NSCLC (Non Small Cell Lung Cancer) prevention comprises the following raw materials: astragalus membranaceus, radix pseudostellariae, radix ophiopogonis, schisandra chinensis, cordyceps sinensis, codonopsis pilosula, bulbus fritillariae cirrhosae, semen armeniacae amarae, folium eriobotryae, houttuynia cordata, angelica sinensis, pseudo-ginseng, cornua cervi pantotrichum, leech, oldenlandia diffusa, selfheal, sculellaria barbata, calculus bovis and centipede. The drug composition achieves medication safety, has no toxic or side effects, has excellent effect, can be used for effectively solving the problem of poor treatment effect of NSCLC, improves the life quality of patients suffering from the middle and advanced stage NSCLC, and prolongs the lifetime of the patients.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a traditional Chinese medicine composition, in particular to a non-small cell lung cancer-resistant medicinal composition and a preparation method thereof. Background technique [0002] Lung cancer is a common clinical malignant tumor. Due to the occult, invasive and metastatic nature of tumor cell growth, most patients with non-small cell lung cancer (English abbreviation: NSCLC) are in stage III or IV at the time of clinical consultation and lose the opportunity for surgery. Chemoradiation has become the main treatment. However, radiotherapy and chemotherapy have the disadvantages of damaging the normal function of the human body, uncertain curative effect, or causing excessive treatment of tumors, which affect the quality of life of patients to varying degrees. Judging from the current treatment, due to the high degree of malignancy and complex biological characteristics of lun...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8968A61P35/00A61K35/62A61K35/32A61K35/413A61K35/648
CPCA61K36/481A61K9/0095A61K9/08A61K35/32A61K35/413A61K35/62A61K35/648A61K36/068A61K36/232A61K36/258A61K36/344A61K36/36A61K36/536A61K36/539A61K36/57A61K36/73A61K36/736A61K36/748A61K36/78A61K36/79A61K36/8966A61K36/8968A61K2236/331A61K2236/39A61K2236/51A61K2236/53
Inventor 李君亢林萍张颖冯雪景
Owner QINGDAO MUNICIPAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products